Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia

• Главные авторы: Michele Wilson (Автор), Benjamin Gutierrez (Автор), Steve J Offord (Автор), Christopher M Blanchette (Автор), Anna Eramo (Автор), Stephanie Earnshaw (Автор), Siddhesh A Kamat (Автор)
• Формат: ‌
• Опубликовано: BioExcel Publishing Ltd, 2016-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Schizophrenia is associated with high direct healthcare costs due to progression of disease and frequent occurrence of relapses. Aripiprazole once-monthly (AOM) has been shown to reduce total psychiatric hospitalizations among patients who switched from oral standard of care (SOC) therap...